Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27451390

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2016 Sep
First author
Younes A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Sep;17(9):1183-4. doi: 10.1016/S1470-2045(16)30220-0.
    note
    Source null
    related pmid
    27451389
    relationship
    Comment in

Authors and identifiers

  1. name
    Younes A
    type
    Author
  2. name
    Santoro A
    type
    Author
  3. name
    Shipp M
    type
    Author
  4. name
    Zinzani PL
    type
    Author
  5. name
    Timmerman JM
    type
    Author
  6. name
    Ansell S
    type
    Author
  7. name
    Armand P
    type
    Author
  8. name
    Fanale M
    type
    Author
  9. name
    Ratanatharathorn V
    type
    Author
  10. name
    Kuruvilla J
    type
    Author
  11. name
    Cohen JB
    type
    Author
  12. name
    Collins G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Younes A
    type
    Author
  2. name
    Santoro A
    type
    Author
  3. name
    Shipp M
    type
    Author
  4. name
    Zinzani PL
    type
    Author
  5. name
    Timmerman JM
    type
    Author
  6. name
    Ansell S
    type
    Author
  7. name
    Armand P
    type
    Author
  8. name
    Fanale M
    type
    Author
  9. name
    Ratanatharathorn V
    type
    Author
  10. name
    Kuruvilla J
    type
    Author
  11. name
    Cohen JB
    type
    Author
  12. name
    Collins G
    type
    Author
bibliography ids
  1. nci-bib-30b576184959cc5e37196848
book metadata
content sha256
1a7e3a4cbd00de202500e93a56996ff288b328ba39a7bc790c43ee3efaaf3b0b
document type
citation
dois
  1. 10.1016/S1470-2045(16)30167-X
electronic publication date
display
2016 Jul 20
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27451390
immutable id
pubmed:27451390@1a7e3a4cbd00de202500e93a56996ff288b328ba39a7bc790c43ee3efaaf3b0b
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
9
name
The Lancet. Oncology
nlm unique id
100957246
pages
1283-94
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Sep;17(9):1183-4. doi: 10.1016/S1470-2045(16)30220-0.
    note
    Source null
    related pmid
    27451389
    relationship
    Comment in
outcomes validated
false
pmid
27451390
provenance
batch id
d649bcb2d98dbbacd53c
provider
NCBI PubMed ESummary
record sha256
7ca2af744934269160361dac541e79cb4ab5178413b3a3882474eb74c763d49d
response sha256
26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
retrieved at
2026-09-09T23:47:20.761544+00:00
publication date
display
2016 Sep
precision
month
year
2016
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27451390/
title
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.

Preserved source evidence · Not medical advice